Clever Leaves Holdings Inc. (CLVRW) Stock Analysis

Clever Leaves Holdings Inc. (CLVRW) Healthcare & Pipeline Overview

Clever Leaves Holdings Inc. is a global cannabis company focused on the cultivation, extraction, and distribution of cannabinoid products, alongside nutraceuticals and wellness products. Operating in the specialty and generic drug manufacturing sector, Clever Leaves aims to capitalize on international cannabis markets and wellness trends.

What Is the Investment Thesis for CLVRW?

Clever Leaves Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's dual-segment strategy, focusing on both cannabinoid and non-cannabinoid products, offers diversification within the health and wellness sector. However, the company's negative profit margin of -102.8% indicates significant challenges in achieving profitability. A high beta of 5.14 suggests high volatility relative to the market. Growth catalysts include expansion into new international markets and the development of innovative cannabis-based products. The company's ability to improve its operational efficiency and achieve positive earnings will be critical for long-term success.

Based on FMP financials and quantitative analysis

CLVRW Key Highlights

Operates in the cannabis industry through two segments: Cannabinoid and Non-Cannabinoid.

• Gross Margin of 37.6% indicates potential for profitability if operational efficiencies improve.
• Negative Profit Margin of -102.8% highlights significant challenges in achieving profitability.
• Beta of 5.14 indicates high volatility compared to the overall market.
• International operations provide exposure to diverse cannabis markets.

Who Are CLVRW's Competitors?

CLVRW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CLVRW's Key Strengths?

Dual-segment strategy (Cannabinoid and Non-Cannabinoid)

• International operations
• Manufacturing capabilities
• Established distribution networks

What Are CLVRW's Weaknesses?

Negative profit margin

• High beta (volatility)
• Dependence on regulatory approvals
• Limited brand recognition

What Could Drive CLVRW Stock Higher?

Potential regulatory approvals in new international markets could expand market access.

• Continued expansion of the product portfolio with innovative cannabis-based products.
• Strategic partnerships and acquisitions to enhance capabilities and market reach.

What Are the Key Risks for CLVRW?

Financial-distress signal — its Altman Z-Score of -10.17 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-55.4%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Changes in regulations could impact the company's ability to operate in certain markets.
• Intense competition could erode market share and profitability.
• Negative profit margin poses a risk to the company's financial sustainability.
• High beta indicates high volatility and potential for significant price fluctuations.

What Are the Growth Opportunities for CLVRW?

• Expansion into New International Markets: Clever Leaves has the opportunity to expand its presence in international markets where cannabis legalization is progressing. This includes countries in Europe, Latin America, and Asia. Successful expansion could significantly increase revenue and market share. The global legal cannabis market is projected to reach $55 billion by 2026, providing a substantial growth opportunity for Clever Leaves.
• Development of Innovative Cannabis-Based Products: Clever Leaves can invest in research and development to create innovative cannabis-based products that meet the evolving needs of consumers. This includes developing new formulations, delivery methods, and product categories. Innovation can differentiate Clever Leaves from its competitors and attract new customers. The market for cannabis-infused products is growing rapidly, with a focus on health and wellness applications.
• Strategic Partnerships and Acquisitions: Clever Leaves can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, nutraceutical manufacturers, and distribution networks. Acquisitions can provide access to new technologies, products, and markets. Strategic alliances can accelerate growth and enhance competitiveness.
• Focus on High-Margin Products: Clever Leaves can focus on developing and marketing high-margin products, such as premium cannabis strains, specialty nutraceuticals, and wellness products. This can improve profitability and increase shareholder value. The market for premium cannabis products is growing, as consumers are willing to pay more for high-quality and unique offerings. Focusing on higher margin products will help offset the negative profit margin.
• Leveraging the Non-Cannabinoid Segment: Clever Leaves can leverage its Non-Cannabinoid segment to generate revenue and diversify its business. The nutraceuticals and wellness products market is large and growing, providing a stable source of income. By expanding its product offerings and distribution channels in this segment, Clever Leaves can reduce its reliance on the cannabis market and mitigate regulatory risks. The global nutraceuticals market is projected to reach $400 billion by 2030.

What Are CLVRW's Competitive Advantages?

• International operations provide access to diverse markets.
• Dual-segment strategy offers diversification.
• Manufacturing capabilities for both cannabinoid and non-cannabinoid products.
• Established distribution networks in the United States.

What Does CLVRW Do?

Founded in 2017 and headquartered in Boca Raton, Florida, Clever Leaves Holdings Inc. operates as a cannabis company with a dual focus on cannabinoid and non-cannabinoid products. The Cannabinoid segment is involved in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabis products on a global scale. This includes various cannabis-derived products aimed at medical and recreational markets where legally permissible. The Non-Cannabinoid segment focuses on the formulation, manufacturing, marketing, selling, and distribution of nutraceuticals, natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. These products are targeted at mass retailers, specialty health retailers, and distributors primarily in the United States. Clever Leaves aims to leverage its cultivation and manufacturing capabilities to establish a strong presence in both the cannabinoid and wellness markets. The company's strategy involves expanding its international footprint and product portfolio to meet the growing demand for cannabis and wellness products.

What Products and Services Does CLVRW Offer?

• Cultivates cannabis plants for cannabinoid extraction.
• Extracts cannabinoids from cannabis plants.
• Manufactures cannabinoid-based products.
• Commercializes and distributes cannabinoid products internationally.
• Formulates nutraceutical and wellness products.
• Manufactures and distributes nutraceutical and wellness products.

How Does CLVRW Make Money?

• Cultivation and extraction of cannabis for cannabinoid production.
• Manufacturing and distribution of cannabinoid-based products.
• Formulation, manufacturing, and distribution of nutraceuticals and wellness products.
• Sales through mass retailers, specialty health retailers, and distributors.

What Industry Does CLVRW Operate In?

Clever Leaves operates within the rapidly evolving cannabis and nutraceuticals industries. The global cannabis market is experiencing significant growth, driven by increasing legalization and acceptance of cannabis for medical and recreational use. The nutraceuticals market is also expanding, fueled by growing consumer interest in health and wellness products. Competition is intense, with numerous companies vying for market share. Clever Leaves' success depends on its ability to differentiate its products, navigate complex regulatory environments, and establish strong distribution networks. The company faces competition from established pharmaceutical companies, as well as other cannabis producers and nutraceutical manufacturers.

Who Are CLVRW's Key Customers?

• Mass retailers in the United States.
• Specialty health retailers in the United States.
• Distributors in the United States.
• International customers in countries where cannabis is legal.

Company Profile

Clever Leaves Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Boca Raton, US. The company is led by CEO Andres Fajardo. CLVRW has traded publicly since 2020.

Return on equity for Clever Leaves Holdings Inc. stands at -55.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -57.3%, showing how much profit it generates from its asset base. A current ratio of 2.40 indicates the company holds enough short-term assets to cover its near-term obligations.

Clever Leaves Holdings Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -10.17 places it in the distress zone, a signal of elevated financial risk.

CLVRW Financials

CLVRW Latest News

No recent news available for CLVRW.

CLVRW Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources